1504 Results for
- View:
- Only Recruiting Trials
-
All Trials
| Study Title | Principal Investigator |
|---|---|
|
A Phase II Simon Two-Stage Study of the Addition of Pracinostat to a Hypomethylating Agent (HMA) in Patients With Myelodysplastic Syndrome (MDS) Who Have Failed to Respond or Maintain a Response to the HMA Alone
Not recruiting | Myelodysplastic Syndromes (MDS) | Multisite
|
|
Powered by
SC CTSI